Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jclinepi.2023.06.013
PubMed Identifier: 37380118
Publication URI: http://europepmc.org/abstract/MED/37380118
Type: Journal Article/Review
Volume: 160
Parent Publication: Journal of clinical epidemiology
ISSN: 0895-4356